INS and Obesity: These data substantiate the role of P300 acetyltransferase activity in the impairment of insulin signaling in obesity and indicate that abnormal cytoplasm-appearing P300 impairs insulin signaling by acetylating IRS1 and IRS2 (Figure 2B).